Conventional epidemiology and the link between SV40 and human cancers

Lancet Oncology

Volumn 4, Issue 3, 2003, Pages 188-191

  Vilchez, Regis A ^a   Kozinetz, Claudia A ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; VIRUS DNA;

CANCER EPIDEMIOLOGY; COHORT ANALYSIS; EXPERIMENTAL ANIMAL; EXPOSURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SIMIAN VIRUS 40; TIME; VIRUS CARCINOGENESIS; VIRUS INFECTION;

EID: 0037342210     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01024-6     Document Type: Review

References (50)

1. Rollison DE, Shah KV. The epidemiology of SV40 infection due to contaminated polio vaccines: relation of the virus to human cancer. In: Khalili K, Stoner GL, (Eds). Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, Inc, 2001: 561-84.
2. Proceedings of the second international conference on live poliovirus vaccines. Washington DC: The Pan American Health Organization and The World Health Organization, 1961.
3. Lewis AM Jr. Experience with SV40 and adenovirus-SV40 hybrids. In: Hellman A, Oxman MN, Pollack R (Eds). Biohazards in biological research. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2973: 96-113.
4. SV40 contamination of polio vaccine and cancer. Presentations and discussions. Washington DC: Institute of Medicine, 2002. http://www.iom.edu/IOM/IOMHome.nsf/Pages/SV40+Agenda, accessed Feb 2003.
5. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999;91:119-34.
6. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-23.
7. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851-52.
8. Rizzo P, Di Resta I, Powers A, et al. Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection. Cancer Res 1999; 59:6103-08.
9. Innis MD. Oncogenesis and poliomyelitis vaccine. Nature 1968; 219: 972-73.
10. Heinonen OP, Shapiro S, Monson RR, et al. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973; 2: 229-35.
11. Farwell JR, Dohrmann GJ, Marrett LD, Meigs JW. Effect of SV40 virus-contaminated polio vaccine on the incidence and type of CNS neoplasms in children: a population-based study. Trans Am Neurol Assoc 1979; 14: 261-64.
12. Geissler E. SV40 and human brain tumors. Prog Med Virol 1990; 37: 211-22.
13. Fisher SG, Weber L, Carbone M. Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 1999; 19: 2173-80.
14. Fraumeni JF, Ederer F, Miller RW. An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 1963; 185: 85-90.
15. Stewart AM, Hewitt D. Aetiology of childhood leukaemia. Lancet 1965; 2: 789-90.
16. Olin P, Giesecke J. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993. Dev Biol Stand 1998; 94: 227-33.
17. Strickler HD, Rosenberg PS, Devesa SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998; 279: 292-95.
18. Carroll-Pankhurst C, Engels EA, Strickler HD, et al. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br J Cancer 2001; 85: 1295-97.
19. Grimes DA, Schultz KF. Cohort studies: marching towards outcomes. Lancet 2002; 359: 341-45.
20. Fang CT, Shau WY. Epidemiology research. Lancet 2002; 360: 258.
21. Melnick JL, Stinebaugh S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962; 109: 965-68.
22. Li RM, Branton MR, Tanawattanacharoen S, et al. Molecular identification of SV40 infections in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13: 2320-30.
23. Vilchez RA, Kozinetz CA, Arrington AS, et al. The molecular evidence of polyomavirus SV40 in human cancers: meta-analysis of controlled studies. Proc Am Assoc Cancer Res 2002; 43: 777 (abstr).
24. Bergsagel DJ, Finegold MJ, Butel JS, et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992; 326: 988-93.
25. Ibelgaufts H, Jones KW. Papovavirus-related RNA sequences in human neurogenic tumours. Acta Neuropathol (Berl) 1982; 56: 118-22.
26. Krieg P, Amtmann E, Jonas D, et al. Episomal simian virus 40 genomes in human brain tumors. Prog Natl Acad Sci USA 1981; 78: 6446-50.
27. Malkin D, Chilton-MacNaeill S, Meister LA, et al. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 2001; 20: 4441-49.
28. Martini F, Iaccheri L, Lazzarin L, et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996; 56: 4820-25.
29. Meinke W, Goldstein DA, Smith RA. Simian virus 40-related DNA sequences in a human brain tumor. Neurology 1979; 29: 1590-94.
30. Suzuki SO, Mizoguchi M, Iwaki T. Detection of SV40 T antigen genome in human gliomas. Brain Tumor Pathology 1997; 14: 125-29.
31. Weggen S, Bayer TA, Von Deimling A, et al. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 2000; 10: 85-92.
32. Weiss AF, Portmann R, Fischer H, et al. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci USA 1975; 72: 609-13.
33. Zhen HN, Zhang X, Bu XY, et al. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRB complexes in human brain tumors. Cancer 1999; 86:2124-2.
34. Dorries K, Loeber G, Meixensberger J. Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology 1987; 160: 268-70.
35. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9: 1781-90.
36. Cristaudo A, Vivaldi A, Sensales G, et al. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40. J Environ Pathol Toxicol Oncol 1995; 14: 29-34.
37. Dhaene K, Verhulst A, Van Marck E. SV40 large T-antien and human pleural mesothelioma: Screening by polymerase chain reaction and tyramine-amplified immunohistochemistry. Virchows Arch Int J Pathol 1999; 435: 1-7.
38. Griffiths DJ, Nicholson AG, Weiss RA. Detection of SV40 sequences in human mesothelioma. Dev Biol Stand 1998; 94: 127-36.
39. Pepper C, Jasani B, Navabi H, et al. Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 1996; 51: 1074-76.
40. Procopio A, Strizzi L, Vianale G, et al. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chrom Cancer 2000; 29: 173-79.
41. Procopio A, Marinacci R, Marinetti MR, et al. SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma. Dev Biol Stand 1998; 94: 361-67.
42. Ramael M, Nagels J, Heylen H, et al. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. Eur Respir J 1999; 14: 1381-86.
43. Rizzo P, Carbone M, Fisher SG, et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999; 116: 470S-73S.
44. Shivapurkar N, Wiethege T, Wistuba II, et al. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. Int J Cancer 2000; 85: 743-45.
45. Strizzi L, Vianale G, Giuliano M, et al. SV40, JC and BK expression in tissue, urine and blood samples from patients with malignant and nonmalignant pleural disease. Anticancer Res 2000; 20: 885-89.
46. Stricker HD, Goedert JJ, and the International SV40 Working Group. A multicenter evaluation of essays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epiemiol Biomarkers Prevent 2001; 10: 523-32.
47. Carbone M, Rizzo P, Procopio A, et al. SV40-like sequences in human bone tumors. Oncogene 1996; 13: 527-35.
48. Mendoza SM, Konishi T, Miller CW. Integration of SV40 in human osteosarcoma DNA. Oncogene 1998; 17: 2457-62.
49. Yamamoto H, Nakayama T, Murakami H, et al. High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. BR J Cancer 2000; 82: 1677-81.
50. Fredricks DN, Relman DA. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin Infect Dis 1999; 29: 475-86.